1887
Volume 2008, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Ascites is a common important feature of chronic liver disease and to determine the extent, causes, clinical presentation and nature of cirrhotic ascites in Qatar a descriptive, prospective study was made of 48 males and 14 females with cirrhotic ascites and a mean age of 562 “12.6 years admitted to the Medical Department, Hamad General Hospital between January 2004 and January 2005. Twenty six were Qatari, the remainder being of various nationalities. The most common cause of cirrhotic ascites was chronic alcoholism, found in 29 (46.8%) patients. Uncomplicated liver cirrhosis was found in 40 (64.5%) patients, complicated liver cirrhosis in 22 (35.5%) patients. At admission, encephalopathy, GI bleeding, and fever were found to be significantly associated with complicated cirrhotic ascites. Results of the study suggest that cirrhotic ascites is common in the State of Qatar with the most common causes being chronic alcoholism followed by chronic viral hepatitis C and B. It is suggested that efforts are needed to prevent and treat these two conditions.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2008.1.16
2008-06-01
2020-01-24
Loading full text...

Full text loading...

References

  1. Gines P, Quintero E, Arroyo V. Compensated cirrhosis: Natural history and prognostic factors. Hepatology. 1987; 7::122128.
    [Google Scholar]
  2. Amico A, Morabito L. prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986; 31::468475.
    [Google Scholar]
  3. Gines P, Arroyo V, Vargas V. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 1991; 325::829835.
    [Google Scholar]
  4. Salerno F, Borroni G, Moser P. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 patients. Am J Gastroenterol. 1993; 88::514519.
    [Google Scholar]
  5. Khan FY. Ascites in the state of Qatar: Aetiology and diagnostic value of ascitic fluid analysis. Singapore Med J. 2007; 48::434439.
    [Google Scholar]
  6. Runyon BA, Montano AA, Akriviadis EA. The serum-ascites albumin gradient is superior to exudate-transudate concept in differential diagnosis of ascites. Ann Intern Med. 1992; 117::215220.
    [Google Scholar]
  7. Runyon BA, Reynolds TB. Approach to the patient with ascites. In: Yamada TAlpers DH, eds. Textbook of gastroenterology. Philadelphia: J.B. Lippincott 1991;:846864.
    [Google Scholar]
  8. Saunders JB, Walters JR, Davies AP, Paton A. A20-year prospective study of cirrhosis. Br Med J (Clin Res Ed). 1981; 282::263266.
    [Google Scholar]
  9. Hislop WS. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed). 1981; 282::819.
    [Google Scholar]
  10. Al Mofleh I. The pattern of chronic liver disease in a hospital population in Riyadh. East Afr Med J. 1988; 65::514519.
    [Google Scholar]
  11. Allam AR, Al Amri SM, Saeed ES. Clinical pattern of ascites in a Saudi series. Saudi Med J;. 1995; 16::4245.
    [Google Scholar]
  12. Al Knawy BA. Etiology of ascites and the diagnostic value of serum-albumen gradient in non-alcohol liver disease. Ann Saudi Med. 1997; 17:1:2628.
    [Google Scholar]
  13. Darwish MA, Faris R, Darwish N, Shouman A, Gadallah M, Al Sharkawy MS, Delman R, Rumbach K, Ao MR, Lemens JD. Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: A community-based study. Am J Trop Med Hyg. 2001; 64::147153.
    [Google Scholar]
  14. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the USA. N Engl J Med. 1999; 340::745750.
    [Google Scholar]
  15. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000; 15:suppl:E3E6.
    [Google Scholar]
  16. Rimola A. Infections in liver disease. In: Mclntyre NBenhamou JPBireher JRizetto MRodes J, eds. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press 1991;:12721284.
    [Google Scholar]
  17. Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am. 1992; 21:1:257275.
    [Google Scholar]
  18. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993; 18:3:353358.
    [Google Scholar]
  19. Pinzello G, Simonetti R, Camma C, Dino O, Miazzo G, Pagliano L. Spontaneous bacterial peritonitis: An update. Gastroenterol Int. 1993; 6::5460.
    [Google Scholar]
  20. Bac DJ, Siersema PD, Mulder PGH, DeMarie S, Wilson JHP. Spontaneous bacterial peritonitis: outcome and predictive factors. Eur J Gastroenterol Hepatol. 1993; 5::635640.
    [Google Scholar]
  21. Cottone M, Turri M, Caltagirone M. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alpha-fetoprotein: A prospective study. Hepatogastroenterology. 1988; 35::101103.
    [Google Scholar]
  22. Tremolada F, Benvegnu L, Drago C. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy. Hepato gastroenterology. 1989; 36::519521.
    [Google Scholar]
  23. Lok ASF, Lai CL. Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology. 1989; 9::110115.
    [Google Scholar]
  24. Oka H, Kurioka N, Kim K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 1990; 12::680687.
    [Google Scholar]
  25. Colombo M, De Franc his R, Del Ninno E. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991; 325::675680.
    [Google Scholar]
  26. Ikeda K, Saito S, Koida I. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993; 18::4753.
    [Google Scholar]
  27. Tsukuma H, Hiyama T, Tanaka S, et al., Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993; 328::17971801.
    [Google Scholar]
  28. Pateron D, Ganne N, Trinchet IC. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994; 20::6571.
    [Google Scholar]
  29. Shah SHA, Hayes PC, Allan PL, Nicoll J, Finlayson N. Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol. 1996; 91::25802583.
    [Google Scholar]
  30. Sherlock S. The haematology of liver disease. In: Sherlock S, ed. Diseases of the liver. 1996;:4348.
    [Google Scholar]
  31. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999; 94::32923296.
    [Google Scholar]
  32. Prihatini J, Lesmana LA, Manan C, Gani RA. Detection of sophageal varices in liver cirrhosis using non-invasive parameters. Acta Med Indones. 2005; 37::126131.
    [Google Scholar]
  33. Schepis F, Camm C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, D'Amico G, Pasta L, Craxl A, Saitta A, Raimondo G. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001; 33::333338.
    [Google Scholar]
  34. Lieberman FL, Hidemura R, Peters RL. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med. 1966; 64::341351.
    [Google Scholar]
  35. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis. 1977; 17::227232.
    [Google Scholar]
  36. Sheer TA, Runyon BA. Spontaneous Bacterial Peritonitis. Dig Dis. 2005; 23::3946.
    [Google Scholar]
  37. Navasa M, Folio A, Llovet JM. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology. 1996; 111::10111017.
    [Google Scholar]
  38. Fernandez J, Navasa M, Gomez J. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002; 35::140148.
    [Google Scholar]
  39. Rimola A, Salmeron JM, Clemente G. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study. Hepatology. 1995; 21::674679.
    [Google Scholar]
  40. Navasa M, Folio A, Filella X. Tumor necrosis factor and inter - leukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality. Hepatology. 1998; 27::12271232.
    [Google Scholar]
  41. Llovet JM, Planas R, Morillas R. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: Multivariate study. Am J Gastroenterol. 1993; 88::388392.
    [Google Scholar]
  42. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis-in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol. 2001; 96::12321236.
    [Google Scholar]
  43. Kim WR, Brown RS, Terrault NA. Burden of liver disease in the United States: Summary of a workshop. Hepatology. 2002; 36::227242.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2008.1.16
Loading
  • Article Type: Research Article
Keyword(s): Alcoholic cirrhosis , cirrhotic ascites and spontaneous bacterial peritonitis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error